Accelerated Reendothelialization, Increased Neovascularization and Erythrocyte Extravasation after Arterial Injury in BAMBI-/- Mice

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Guillot, Nicolas ^a   Kollins, Dmitrij ^a   Badimon, Juan J ^a   Schlondorff, Detlef ^a   Hutter, Randolph ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BMP ACTIVIN MEMBRANE BOUND INHIBITOR PROTEIN; MEMBRANE PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY WALL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; BLEEDING; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE EXTRAVASATION; EXTRAVASATION; FEMORAL ARTERY; GENE DELETION; GENOTYPE; HISTOGENESIS; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; REENDOTHELIALIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE REPAIR; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ERYTHROCYTES; FEMORAL ARTERY; HEMORRHAGE; MALE; MEMBRANE PROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TUNICA INTIMA; VASCULAR SYSTEM INJURIES; WOUND HEALING;

EID: 84874573616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058550     Document Type: Article

References (23)

1. Khan R, Agrotis A, Bobik A, (2007) Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res 74: 223-234.
2. Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, et al. (1998) Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A 95: 6983-6988.
3. Wolf YG, Rasmussen LM, Ruoslahti E, (1994) Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest 93: 1172-1178.
4. Goumans MJ, Liu Z, ten Dijke P, (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res 19: 116-127.
5. Grainger DJ, (2004) Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24: 399-404.
6. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J, (2007) TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74: 196-206.
7. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, et al. (1999) Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401: 480-485.
8. Paulsen M, Legewie S, Eils R, Karaulanov E, Niehrs C, (2011) Negative feedback in the bone morphogenetic protein 4 (BMP4) synexpression group governs its dynamic signaling range and canalizes development. Proc Natl Acad Sci U S A 108: 10202-10207.
9. Guillot N, Kollins D, Gilbert V, Xavier S, Chen J, et al. (2012) BAMBI Regulates Angiogenesis and Endothelial Homeostasis through Modulation of Alternative TGFbeta Signaling. PLoS One 7: e39406.
10. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, et al. (2004) Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110: 2430-2435.
11. Hutter R, Sauter BV, Reis ED, Roque M, Vorchheimer D, et al. (2003) Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation 107: 1658-1663.
12. Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R, (2007) The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 45: 482-486.
13. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, et al. (2000) Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 20: 335-342.
14. Carstairs KC, (1965) The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol 90: 225-231.
15. Gallo R, Padurean A, Toschi V, Bichler J, Fallon JT, et al. (1998) Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 97: 581-588.
16. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, et al. (1992) Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 90: 1582-1592.
17. Madri JA, Reidy MA, Kocher O, Bell L, (1989) Endothelial cell behavior after denudation injury is modulated by transforming growth factor-beta1 and fibronectin. Lab Invest 60: 755-765.
18. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA, (1991) Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 88: 904-910.
19. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, et al. (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: II365-371.
20. Fay WP, (2004) Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Trends Cardiovasc Med 14: 196-202.
21. Seki T, Yun J, Oh SP, (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93: 682-689.
22. Orlova VV, Liu Z, Goumans MJ, ten Dijke P, (2011) Controlling angiogenesis by two unique TGF-beta type I receptor signaling pathways. Histol Histopathol 26: 1219-1230.
23. Grainger DJ, Kemp PR, Witchell CM, Weissberg PL, Metcalfe JC, (1994) Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. Biochem J 299 (Pt 1): 227-235.